Vicore Pharma Holding AB (publ) (STO:VICO)
11.08
+0.34 (3.17%)
Aug 22, 2025, 5:29 PM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 1.75M SEK in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.74M, down -92.57% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.
Revenue (ttm)
7.74M
Revenue Growth
-92.57%
P/S Ratio
335.81
Revenue / Employee
234.58K
Employees
29
Market Cap
2.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 109.35M | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.52B |
AddLife AB | 10.44B |